文献速递肿瘤 PET/CT

头颈癌放疗后基于PET的预后生存模型

PET-based prognostic survival model after radiotherapy for head and neck cancer.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2018-08-21

这项多中心回顾性研究纳入237例接受根治性放疗的局部晚期头颈癌患者,分为训练队列127例和验证队列110例,分析原发肿瘤及淋巴结的18F-FDG PET参数。多因素分析确定肿瘤部位、p16状态、原发肿瘤MTV35%和淋巴结MTV44%为总生存的独立预测因子,构建的预后模型c-index为0.72,外部验证c-index为0.66。

要点

  • 原发肿瘤MTV和TLG在多种相对及绝对阈值下均与总生存相关。
  • 淋巴结MTV和TLG无论阈值如何均与总生存相关。
  • 基于肿瘤部位、p16状态、原发肿瘤MTV35%和淋巴结MTV44%的模型c-index为0.72,外部验证为0.66。

核心结论

  • 研究提出并验证了一个基于原发肿瘤和淋巴结MTV、肿瘤部位及p16状态的总生存预后模型。
  • 相应的列线图可能用于个体化治疗。

研究设计与样本

  • 多中心回顾性研究,连续纳入237例接受根治性放疗的局部晚期头颈癌患者,分为训练队列127例和验证队列110例。
  • 分析原发肿瘤和淋巴结的SUVMax、MTV、TLG和SUVMean,采用相对SUVMax阈值或绝对SUV阈值。
  • 在训练队列中对总生存进行Cox分析,使用c-index识别高预后价值参数,构建预后模型并生成列线图,在验证队列进行外部验证。

主要发现

  • 单因素分析中,原发肿瘤的显著PET参数包括MTV(相对阈值6%至83%,绝对阈值1.5至6.5)和TLG(相对阈值1%至82%,绝对阈值0.5至4.5)。
  • 淋巴结的显著参数包括MTV和TLG,无论阈值取值如何。
  • 多因素分析中,肿瘤部位、p16状态、原发肿瘤MTV35%和淋巴结MTV44%是总生存的独立预测因子。
  • 基于这四个参数构建的预后模型c-index为0.72,外部验证c-index为0.66。

关键数值与推荐

  • 原发肿瘤MTV显著相关的相对阈值范围为6%至83%,绝对阈值范围为1.5至6.5。
  • 原发肿瘤TLG显著相关的相对阈值范围为1%至82%,绝对阈值范围为0.5至4.5。
  • 多因素分析中纳入模型的参数为肿瘤部位、p16状态、原发肿瘤MTV35%和淋巴结MTV44%。
  • 预后模型在训练队列的c-index为0.72,在验证队列的外部验证c-index为0.66。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The aims of this multicentre retrospective study of locally advanced head and neck cancer (LAHNC) treated with definitive radiotherapy were to (1) identify positron emission tomography (PET)-18F-fluorodeoxyglucose (18F-FDG) parameters correlated with overall survival (OS) in a training cohort, (2) compute a prognostic model, and (3) externally validate this model in an independent cohort. MATERIALS AND METHODS: A total of 237 consecutive LAHNC patients divided into training (n = 127) and validation cohorts (n = 110) were retrospectively analysed. The following PET parameters were analysed: SUVMax, metabolic tumour volume (MTV), total lesion glycolysis (TLG), and SUVMean for the primary tumour and lymph nodes using a relative SUVMax threshold or an absolute SUV threshold. Cox analyses were performed on OS in the training cohort. The c-index was used to identify the highly prognostic parameters. A prognostic model was subsequently identified, and a nomogram was generated. The model was externally tested in the validation cohort. RESULTS: In univariate analysis, the significant PET parameters for the primary tumour included MTV (relative thresholds from 6 to 83% and absolute thresholds from 1.5 to 6.5) and TLG (relative thresholds from 1 to 82% and absolute thresholds from 0.5 to 4.5). For the lymph nodes, the significant parameters included MTV and TLG regardless of the threshold value. In multivariate analysis, tumour site, p16 status, MTV35% of the primary tumour, and MTV44% of the lymph nodes were independent predictors of OS. Based on these four parameters, a prognostic model was identified with a c-index of 0.72. The corresponding nomogram was generated. This prognostic model was externally validated, achieving a c-index of 0.66. CONCLUSIONS: A prognostic model of OS based on primary tumour and lymph node MTV, tumour site, and p16 status was proposed and validated. The corresponding nomogram may be used to tailor individualized treatment.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Castelli J, Depeursinge A, Devillers A, et al. PET-based prognostic survival model after radiotherapy for head and neck cancer. Eur J Nucl Med Mol Imaging. 2018. PMID: 30132054. doi:10.1007/s00259-018-4134-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。